개인구독
소속 기관이 없으신 경우, 개인 정기구독을 하시면 저렴하게
논문을 무제한 열람 이용할 수 있어요.
지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 저널정보
- 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제16권 제13호
- 발행연도
- 2015.1
- 수록면
- 5,585 - 5,585 (1page)
이용수
초록· 키워드
오류제보하기
등록된 정보가 없습니다.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
The Role of Neoadjuvant Treatment in Resectable Pancreatic Cancer
대한외과학회 학술대회 초록집
2019 .10
-
Is Neoadjuvant Therapy Needed in Patients with Resectable Pancreatic Cancer?
Gut and Liver
2022 .01
-
Great Debates: Which is the Best? Resectable pancreatic cancer: Neoadjuvant treatment first
대한임상종양학회 학술대회지
2019 .02
-
Surgical strategy for borderline resectable pancreatic cancer
한국간담췌외과학회 학술대회지
2017 .03
-
Clinical significance of defining borderline resectable pancreatic cancer
한국간담췌외과학회 학술대회지
2017 .03
-
Current Definition of Borderline Resectable Pancreatic Cancer and Its Limitation
한국간담췌외과학회 학술대회지
2017 .03
-
Validation of anatomical and biological definition of borderline resectable cancer according to the 2017 international consensus for survival in patients with resectable and borderline resectable pancreatic ductal adenocarcinoma undergoing upfront surgery
대한임상종양학회 학술대회지
2022 .02
-
Clinical Outcomes of the Borderline Resectable Pancreatic Cancer according to the Neoadjuvant Chemo-Regimens: Gemcitabine vs. FOLFIRINOX
대한외과학회 학술대회 초록집
2019 .10
-
Does Current Staging System Applicable for Borderline Resectable or Locally Advanced Pancreatic Cancer after Neoadjuvant Chemotherapy?
대한외과학회 학술대회 초록집
2022 .05
-
Validation of anatomical and biological definition of borderline resectable pancreatic cancer according to the 2017 international consensus for survival in patients with resectable and borderline rese
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
-
Corrigendum to: Is Neoadjuvant Therapy Needed in Patients with Resectable Pancreatic Cancer?
Gut and Liver
2023 .03
-
The change of clinical stage after neoadjuvant chemotherapy in prediction of prognosis for borderline resectable and locally advanced pancreatic cancer
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
-
Advances in neoadjuvant therapy for resectable pancreatic cancer over the past two decades
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .05
-
Development of Deep Learning Prognostic Model for Resectable Pancreatic Cancer
대한외과학회 학술대회 초록집
2021 .11
-
Role of neoadjuvant treatment for resectable pancreatic ductal adenocarcinoma
한국간담췌외과학회 학술대회지
2017 .03
-
Resection first, if it is resectable
한국간담췌외과학회 학술대회지
2016 .04
-
Inflammatory and nutritional markers in patients with resectable pancreatic cancer
KOREAN JOURNAL OF CLINICAL ONCOLOGY
2023 .06
-
Oncologic Benefits of Neoadjuvant Treatment versus Upfront Surgery in Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-analysis
대한외과학회 학술대회 초록집
2022 .11
-
A Prospective Multicenter Study of Partially Covered Metal Stents in Patients Receiving Neoadjuvant Chemotherapy for Resectable and Borderline Resectable Pancreatic Cancer: BTS-NAC Study
Gut and Liver
2021 .01
-
The decrease or normalization of carbohydrate antigen 19-9 have comparable prognostic performance in patients with borderline resectable and locally advanced pancreatic cancer after neoadjuvant chemotherapy
대한외과학회 학술대회 초록집
2019 .10
이 논문의 저자 정보
최근 본 자료
댓글(0)
0